Novartis AG NVS
Set alert
159.98 USD -1.54 -0.95%
As of Nov 3, 2:07 PM ET
159.69 Day range 161.77
123.24 52-week range 170.46
- YTD
- +16.04%
- 1 year
- +29.16%
- Open
- 161.31
- Prev close
- 161.52
- Mkt cap
- 302.26B
- Vol
- 648.70K
- Avg vol
- 2.05M
- EPS
- 5.24
- P/E
- 30.54
- Div yield
- 1.91%
More statistics
- Low
- 159.69
- High
- 161.77
- Forward P/E
- 16.25
- Beta
- 0.46
- Short ratio
- 3.01
- Inst. own
- 7.30%
- Dividend
- 4.74
- Ex-div date
- Mar 10, 2026
- Earnings
- Feb 3, 2027
- 50-d avg
- 148.40
- 200-d avg
- 151.81
- 1y target
- 154.80
5Y chart
Events in this range
- Mar 8, 2022Dividend: 3.32525
- Mar 9, 2023Dividend: 3.4987
- Mar 7, 2024Dividend: 3.19863
- Sep 24, 2024Dividend: 3.77721
- Mar 12, 2025Dividend: 3.99399
- Sep 12, 2025Downgrade: Goldman Sachs · Neutral → Sell
- Oct 28, 2025Earnings: 2.25; estimate 2.26; surprise -0.44%
- Dec 8, 2025Rating: JP Morgan · Neutral → Overweight
- Jan 6, 2026Rating: Barclays · Underweight → Equal-Weight
- Feb 4, 2026Earnings: 2.03; estimate 1.99; surprise 2.01%
- Mar 11, 2026Dividend: 4.74025
- Mar 26, 2026Rating: Morgan Stanley · Overweight → Overweight
- Apr 28, 2026Earnings: 1.99; estimate 2.11; surprise -5.69%
- Jul 21, 2026Earnings: 2.41; estimate 2.17; surprise 11.06%
- Sep 10, 2026Rating: HSBC · Reduce → Hold
- Oct 27, 2026Earnings: 2.46; estimate 2.25; surprise 9.33%
- Oct 30, 2026Downgrade: Deutsche Bank · Hold → Sell
Signals (92)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 26, 2026 | 1 week ago |
| SMA: Bullish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| MACD: Sell Signal | Mar 16, 2026 | 7 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
Newest 20 of 92.
Analyst view
Consensus: hold
Hold
Price target (mean) 154.80 -3.2% downside
Now 159.98
- Target (low)
- 130.00
- Target (mean)
- 154.80
- Target (high)
- 185.00
Ratings (0m) 11 5 buy · 4 hold · 2 sell
- Strong buy3
- Buy2
- Hold4
- Sell1
- Strong sell1
Recommendation trend
- This month 11
- 1 month ago 12
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.23 | 2.19 – 2.31 | 2.03 | +9.9% | 14.85B | +7.1% | 3 |
| Next quarter | 2.27 | 2.21 – 2.33 | 1.99 | +14.1% | 14.31B | +5.8% | 2 |
| Current year | 9.16 | 9.01 – 9.38 | 8.98 | +2.0% | 57.38B | +1.3% | 5 |
| Next year | 9.94 | 9.30 – 10.79 | 9.16 | +8.5% | 61.50B | +7.2% | 9 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | Deutsche Bank | Downgrade | Hold | Sell |
| Sep 10, 2026 | HSBC | Upgrade | Reduce | Hold |
| Mar 26, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jan 6, 2026 | Barclays | Upgrade | Underweight | Equal-Weight |
| Dec 8, 2025 | JP Morgan | Upgrade | Neutral | Overweight |
| Sep 12, 2025 | Goldman Sachs | Downgrade | Neutral | Sell |
| Feb 13, 2025 | UBS | Downgrade | Buy | Neutral |
| Nov 19, 2024 | Erste Group | Downgrade | Buy | Hold |
| Oct 30, 2024 | BMO Capital | Maintained | Market Perform | Market Perform |
| Sep 11, 2024 | B of A Securities | Downgrade | Buy | Neutral |
| Sep 5, 2024 | Goldman Sachs | Downgrade | Buy | Neutral |
| Sep 3, 2024 | Jefferies | Downgrade | Buy | Hold |
| Jul 2, 2024 | Jefferies | Maintained | Buy | Buy |
| Apr 24, 2024 | BMO Capital | Maintained | Market Perform | Market Perform |
| Feb 23, 2024 | BMO Capital | Initiated | — | Market Perform |
| Jan 23, 2024 | Morgan Stanley | Initiated | — | Equal-Weight |
| Sep 25, 2023 | Morgan Stanley | Upgrade | Underweight | Equal-Weight |
| May 9, 2022 | Wolfe Research | Downgrade | Outperform | Peer Perform |
| Dec 6, 2021 | Exane BNP Paribas | Downgrade | Outperform | Neutral |
| Dec 3, 2021 | Bryan Garnier | Downgrade | Buy | Neutral |
| Sep 20, 2021 | Deutsche Bank | Downgrade | Hold | Sell |
| Mar 10, 2021 | Argus Research | Downgrade | Buy | Hold |
| Feb 1, 2021 | Cowen & Co. | Downgrade | Outperform | Market Perform |
| Jan 15, 2021 | Deutsche Bank | Initiated | — | Buy |
| Sep 1, 2020 | Morgan Stanley | Upgrade | Equal-Weight | Overweight |
| Feb 25, 2020 | Guggenheim | Downgrade | Buy | Neutral |
| Apr 25, 2019 | Guggenheim | Upgrade | Neutral | Buy |
| Apr 10, 2019 | Morgan Stanley | Downgrade | Equal-Weight | Underweight |
| Nov 26, 2018 | Cowen & Co. | Upgrade | Market Perform | Outperform |
| Nov 19, 2018 | Goldman Sachs | Upgrade | Neutral | Conviction Buy |